Core Alternative Capital’s Cardinal Health CAH Stock Holding History

Core Alternative Capital’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-29	Closed	-$2.19K	–	375
2023 Q1	$2.19K	Buy	+29	New	+$2.19K	﹤0.01%	378

Other funds holding CAH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Core Alternative Capital's CAH Position: Q2 2023 in Review

Core Alternative Capital sold out of Cardinal Health (CAH) in Q2 2023, closing a stake of 29 shares — an estimated $2.19K sold.

Core Alternative Capital first reported a position in CAH in Q1 2023 and held it in 1 quarter. The position peaked at $2.19K in Q1 2023. 948 funds tracked by Wall St. Rank hold CAH as of Q2 2023.

Core Alternative Capital reported no remaining Cardinal Health position as of Q2 2023 after selling out during the quarter.
Core Alternative Capital sold 29 Cardinal Health shares in Q2 2023, an estimated $2.19K.
Core Alternative Capital first reported a position in Cardinal Health in Q1 2023 and held it in 1 quarter.
Core Alternative Capital's Cardinal Health position peaked at $2.19K in Q1 2023.
948 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2023.

Based on Core Alternative Capital's 13F filing for Q2 2023, filed 27 Jul 2023.